Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma
Ian Pavord, Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Robert R. Johnson, Sivan Harel, Michel Djandji, Ledia Goga, Nora Crikelair, Paul J. Rowe, William W. Busse
Topics & Concepts
DupilumabMedicinePlaceboAsthmaInternal medicineEosinophilBiomarkerPost-hoc analysisClinical trialImmunologyGastroenterologyPathologyBiochemistryAlternative medicineChemistryAsthma and respiratory diseasesEosinophilic EsophagitisDelphi Technique in Research